Evidence map›Paper›PMID 30613275›Full record

ArticleTheranostics2018

Delivery of miR-146a to Ly6C

Meryem Ammari, Jessy Presumey, Clara Ponsolles, Gautier Roussignol, Christine Roubert, Virginie Escriou, Karine Toupet, Anne-Laure Mausset-Bonnefont, Maïlys Cren, Maxime Robin and 11 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Exacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesis.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Frontiers in microbiology · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 4 countries.

Meryem AmmariIRMB, INSERM, University of Montpellier, Montpellier, France.
Jessy PresumeyIRMB, INSERM, University of Montpellier, Montpellier, France.
Clara PonsollesIRMB, INSERM, University of Montpellier, Montpellier, France.
Gautier RoussignolExploratory Unit, Sanofi R & D, Montpellier, France.
Christine RoubertExploratory Unit, Sanofi R & D, Montpellier, France.
Virginie EscriouUTCBS, CNRS, INSERM, Université Paris Descartes, Sorbonne-Paris-Cité, Chimie ParisTech, PSL Research University, Paris, France.
Karine ToupetIRMB, INSERM, University of Montpellier, Montpellier, France.
Anne-Laure Mausset-BonnefontIRMB, INSERM, University of Montpellier, Montpellier, France.
Maïlys CrenIRMB, INSERM, University of Montpellier, Montpellier, France.
Maxime RobinIRMB, INSERM, University of Montpellier, Montpellier, France.
Philippe GeorgelCentre de Recherche d'Immunologie et d'Hématologie, INSERM, CNRS, University of Strasbourg, Strasbourg, France.
Ramzi NehmarCentre de Recherche d'Immunologie et d'Hématologie, INSERM, CNRS, University of Strasbourg, Strasbourg, France.
Leonie TaamsCentre for Inflammation Biology and Cancer Immunology, Department of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, London UK.
Joachim GrünDeutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz-Association, Berlin, Germany.
Andrea GrützkauDeutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz-Association, Berlin, Germany.
Thomas HäuplRheumatologie, La Charité, Berlin, Germany.
Yves-Marie PersIRMB, INSERM, University of Montpellier, Montpellier, France.
Christian JorgensenIRMB, INSERM, University of Montpellier, Montpellier, France.
Isabelle Duroux-RichardIRMB, INSERM, University of Montpellier, Montpellier, France.
Gabriel CourtiesCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, 185 Cambridge St, Boston, MA 02114, USA.
Florence ApparaillyIRMB, INSERM, University of Montpellier, Montpellier, France.
Inserm · FRCentre National de la Recherche Scientifique · FRSanofi (France) · FRBoston Children's Hospital · USDélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell DifferentiationAnimalsAntigens, LyArthritisArthritis, RheumatoidBone and BonesDisease Models, AnimalFlow CytometryHumansMice, Inbred C57BLMice, Inbred DBAMice, KnockoutMicroRNAsMonocytesOsteoclastsAntigens, LyLy-6C antigen, mouseMicroRNAsMIRN146 microRNA, humanMirn146 microRNA, mousearthritisbone erosionmiR-146monocyte subsetsosteoclast

Identifiers

PMID30613275
PMCPMC6299444
OpenAlexW2902935147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.